Hospital
Avera ST Anthonys Hospital
Avera ST Anthonys Hospital was paid $1.56M by Medicaid between Jan 2018 and Oct 2024, across 56 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.
33Billing provider infoAVERA ST ANTHONYS HOSPITAL
O'NEILL, NE 68763
O'NEILL, NE 68763
33aNPI1891738936assigned 06/14/2006
33bProvider typeCritical Access Hospital
28Total paid$1.56M
24GClaims41,498
24DCodes billed56
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Critical Access Hospital providers in Nebraska
Rank by total paid#8 of 53
Median peer was paid$593K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,939 | $175K | |
| 2019 | 5,474 | $232K | |
| 2020 | 5,698 | $226K | |
| 2021 | 9,807 | $367K | |
| 2022 | 11,995 | $437K | |
| 2023 | 3,337 | $115K | |
| 2024incomplete | 248 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 1,533 | 1,184 | $234K |
| 80053 | Comprehensive metabolic panel | 11% | 3,658 | 2,903 | $167K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 5,601 | 4,431 | $164K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8.2% | 1,531 | 332 | $128K |
| J3490 | Unclassified drugs | 5.8% | 5,966 | 1,217 | $91K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.4% | 825 | 699 | $84K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.4% | 744 | 607 | $68K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.7% | 1,390 | 703 | $58K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.1% | 3,010 | 2,085 | $49K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.8% | 1,234 | 1,185 | $43K |
| J7030 | Infusion, normal saline solution , 1000 cc | 2.5% | 621 | 439 | $39K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.5% | 1,301 | 1,259 | $39K |
44 more codes
| 99284 | Emergency room visit (serious) | 2.4% | 217 | $37K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 1,020 | $36K |
| 99285 | Emergency room visit (most serious) | 2.2% | 91 | $35K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 524 | $25K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 1,275 | $24K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 2,780 | $24K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 954 | $18K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.1% | 408 | $17K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 287 | $17K |
| 80061 | Lipid panel | 1.0% | 593 | $16K |
| 81001 | 1.0% | 1,169 | $16K | |
| 81003 | <1% | 735 | $12K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 859 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 549 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 104 | $10K |
| 87807 | <1% | 160 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 170 | $9K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 75 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 167 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 199 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 70 | $7K |
| 86140 | <1% | 241 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 261 | $7K |
| 84439 | <1% | 144 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 89 | $4K |
| J2704 | Injection, propofol, 10 mg | <1% | 46 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 40 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 87 | $2K |
| 97161 | <1% | 40 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 36 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16 | $1K |
| 83735 | <1% | 51 | $1K | |
| 81025 | <1% | 39 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 15 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 45 | $441.26 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $439.04 |
| 87186 | <1% | 13 | $231.20 | |
| 85027 | <1% | 13 | $165.90 | |
| 87077 | <1% | 14 | $163.20 | |
| 85610 | <1% | 13 | $158.96 | |
| 11721 | <1% | 23 | $106.18 | |
| A9270 | Non-covered item or service | <1% | 391 | $85.73 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 32 | $45.28 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONSBRUCK, TODD (CEO)
| Provider | Location | Paid |
|---|---|---|
| Avera ST Anthonys Hospital | Oneill, NE | $2.27M |
| City of Sleepy Eye | Sleepy Eye, MN | $1.34M |
| City of Sleepy Eye | Sleepy Eye, MN | $338K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.